Year-to-date money raised in public, private and other financings of biopharma companies.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: 858, Annexon, Arbele, Complement, Intent, Invivyd, Moonlake, Plus, Revolution, RVL, Vanda, Vectory.

Biopharma happenings, including deals and partnerships, and other news in brief: Acertis, Alida, Bayer, Boehringer Ingelheim, Bostongene, Daiichi, Dexcel, Enara, Foresee, Gordian, Halozyme, IBSA, Johnson & Johnson, Lexeo, Nxera, Organon, Orexo, Ottimo, Pfizer, Primevera, Rakovina, Santhera, Soufflé, Storm, Takeda, Variational.

Clinical updates, including data readouts and publications: Agomab, Antag, Biovaxys, Coya, Enliven, Enterobiotix, Epicrispr, Epirium, Eupraxia, Imbria, Kahr, Renovorx, Reviva, Sobi, Sustained, Tvardi, Virometix.

Biopharmas raising money in public or private financings, including: 32 Biosciences, Aktis, Alumis, Alveus, Arrowhead, Beacon, Bright Minds, Century, Diagonal, Engitix, Enodia, Epibiologics, Genelux, Invea, Parabilis, Phathom, Spruce.

New hires and promotions in the biopharma industry, including: Anavex, Anika, Aronora, Astrazeneca, Eleva, Enara, Flagship, Glycoera, Jasper, Onco3r, Psilera, Tango, Tubulis, Turn, Viatris, Xilio.

New hires and promotions in the med-tech industry, including: Delfi Diagnostics, Enhanced Genomics, Illumina, Merit Medical Systems, Pulse Biosciences.

Med-tech firms raising money in public or private financings, including: Daisy Genomics, Apella, Femhealth Ventures, Fineheart, Inito, Pomelo Care.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Omanda Health, Skylinedx.